Hudson Bay Capital Management »

Aptevo Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Aptevo Therapeutics (APVO) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Aptevo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aptevo Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aptevo Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $153k 500k 0.31

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Eli Lilly & Co. Put Option (LLY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Dollar Tree Put Option (DLTR)
Brookfield Corp Cl A Ltd Vt Sh Put Option (BN)
Taiwan Semiconductor Mfg Sponsored Ads Put Option (TSM)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Put Option (AMD)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Meta Platforms Cl A Put Option (META)
Broadcom Put Option (AVGO)
Boeing Company Put Option (BA)

View all positions for Hudson Bay Capital Management

Top funds holding Aptevo Therapeutics

Armistice Capital
Hudson Bay Capital Management
Hrt Financial
Baader Bank
Geode Capital Management
Virtu Financial
Tower Research Capital
BlackRock
Qube Research & Technologies
Morgan Stanley
Bank of America Corporation
Advisor Group Holdings
Jpmorgan Chase & Co
Wells Fargo & Company
Fifth Third Bancorp

View all funds holding Aptevo Therapeutics